Related references
Note: Only part of the references are listed.Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
Claire E. H. Barber et al.
PEDIATRIC RHEUMATOLOGY (2020)
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis
Ariane Klein et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
Bin Huang et al.
RMD OPEN (2020)
Trends in Population-Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada
Natalie J. Shiff et al.
ARTHRITIS CARE & RESEARCH (2019)
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
Nienke M. ter Haar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
Michelle M. A. Kip et al.
PEDIATRIC RHEUMATOLOGY (2019)
Systemic Juvenile Idiopathic Arthritis
Jennifer J. Y. Lee et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2018)
Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis
Sebastiaan J. Vastert et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
Joost F. Swart et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review
Rebecca Davies et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom
Aris Angelis et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
[Anonymous]
HEALTH TECHNOLOGY ASSESSMENT (2016)
Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis
Nadia J. Luca et al.
ARTHRITIS CARE & RESEARCH (2016)
Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population
Swaantje Barth et al.
PLOS ONE (2016)
Disease modifying anti-rheumatic drugs in juvenile idiopathic arthritis: striving for individualized therapy
Ryan S. Funk et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2016)
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
A. Kuhlmann et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Dates and Times Made Easy withlubridate
Garrett Grolemund et al.
Journal of Statistical Software (2015)
Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study
Sebastiaan J. Vastert et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Impact of juvenile idiopathic arthritis on schooling
Ilham Bouaddi et al.
BMC PEDIATRICS (2013)
The financial burden of juvenile idiopathic arthritis: a Nova Scotia experience
Andrea Ens et al.
PEDIATRIC RHEUMATOLOGY (2013)
Juvenile idiopathic arthritis
Berent Prakken et al.
LANCET (2011)
Time to Treatment as an Important Factor for the Response to Methotrexate in Juvenile Idiopathic Arthritis
H. M. Albers et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Juvenile idiopathic arthritis
Angelo Ravelli et al.
LANCET (2007)
Economic impact of juvenile idiopathic arthritis
Sasha Bernatsky et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Current management of juvenile idiopathic arthritis
CA Wallace
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Medical treatment of juvenile idiopathic arthritis
PJ Hashkes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Quality of life and psychosocial adaptation in children and adolescents with juvenile idiopathic arthritis and reactive arthritis
E Müller-Godeffroy et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2005)
Burden and cost of illness in patients with juvenile idiopathic arthritis
K Minden et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Share Paper
